Rajesh C Md Shrotriya
CIK 1193918 · Chairman & CEO · last filed 2023-02-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SPPI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
IRVINE, CA 92618
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GTBP | Director | — | $5.30 | — | $0 | 3 | 2023-02-01 |
| CASI Pharmaceuticals, Inc. (CASI) Delisted | Director | — | $0.28 | — | $0 | 9 | 2022-05-26 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 1,292,041 | $1.03 | $1.33M | -$25.12M | 71 | 2018-05-17 |
Recent Filings · Page 5 of 9
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-12-20 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Tax (F) | −17,110 | -$141.0K | EDGAR |
| 2013-12-17 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
| 2013-12-03 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Tax (F) | −62,925 | -$603.5K | EDGAR |
| 2013-09-05 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Exer (M) | +403,948 | $1.38M | EDGAR |
| 2013-01-07 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Tax (F) | −23,344 | -$272.2K | EDGAR |
| 2013-01-02 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −378,343 | -$4.27M | EDGAR |
| 2012-12-21 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Mixed | +148,411 | $1.68M | EDGAR |
| 2012-12-03 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Tax (F) | −54,675 | -$612.4K | EDGAR |
| 2012-10-11 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −11,350 | -$141.9K | EDGAR |
| 2012-09-20 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −70,800 | -$910.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.